Shanxi Hongxiang Yixintang Pharmaceutical Co., Ltd. announced that it will receive CNY 100,000,000 in an equity round of funding on February 8, 2018. The transaction will include participation from existing investor, Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727). On closing, the registered capital of the company will increase from CNY 138,000,000 to CNY 238,000,000. On closing, the investor will continue to retain its 100% stake in the company. The transaction was approved at the 5th session of 4th directorate of the investor.